Cfs Investment Advisory Services, LLC Biomea Fusion, Inc. Transaction History
Cfs Investment Advisory Services, LLC
- $1.22 Billion
- Q2 2025
A detailed history of Cfs Investment Advisory Services, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cfs Investment Advisory Services, LLC holds 11,468 shares of BMEA stock, worth $25,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,468Holding current value
$25,344% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$8.48 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$7.89 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$5.18 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$4.53 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$4.15 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $64.7M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...